We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

    • Wellcome Sanger Institute

    Health

    Mayo Clinic Study Reveals Genetic Cancer Risks in 550 Patients

    Mayo Clinic study reveals genetic cancer risks in 550 patients, with many carriers of hereditary mutations unaware of their risk. Lead author stresses the importance of early detection for proactive screenings and targeted therapies. Disparities in genetic screening guidelines for underrepresented minorities also highlighted.

    Posted on Jhon
    Health

    Groundbreaking Research Project Investigates Stem Cell Mutations in Rare Blood Disorder

    SKAN Research Trust, Wellcome Sanger Institute, and University of Newcastle collaborate on a groundbreaking research project to investigate early stem cell mutations in Langerhans Cell Histiocytosis (LCH). Led by Dr. Jyoti Nangalia, the study aims to analyze genetic mutations, understand disease progression, and identify early intervention strategies for effective management. This research endeavors to shed light on the complexities of LCH and potentially pave the way for personalized treatment approaches.

    Posted on Jhon
    Health

    Machine Learning Revolutionizes Drug Discovery in Cancer Treatment

    Machine learning has revolutionized the field of drug discovery, leading to the identification of numerous previously unknown drug targets for various types of cancer. A recent study published in Cancer Cell by scientists from the Wellcome Sanger Institute has unveiled…

    Posted on Jhon